These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35780235)

  • 1. Low-dose sodium-glucose cotransporter 2 inhibitor ameliorates ischemic brain injury in mice through pericyte protection without glucose-lowering effects.
    Takashima M; Nakamura K; Kiyohara T; Wakisaka Y; Hidaka M; Takaki H; Yamanaka K; Shibahara T; Wakisaka M; Ago T; Kitazono T
    Commun Biol; 2022 Jul; 5(1):653. PubMed ID: 35780235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Sigma-1 Receptor Enhanced Pericyte Survival via the Interplay Between Apoptosis and Autophagy: Implications for Blood-Brain Barrier Integrity in Stroke.
    Zhang Y; Zhang X; Wei Q; Leng S; Li C; Han B; Bai Y; Zhang H; Yao H
    Transl Stroke Res; 2020 Apr; 11(2):267-287. PubMed ID: 31290080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pericyte-Mediated Tissue Repair through PDGFRβ Promotes Peri-Infarct Astrogliosis, Oligodendrogenesis, and Functional Recovery after Acute Ischemic Stroke.
    Shibahara T; Ago T; Nakamura K; Tachibana M; Yoshikawa Y; Komori M; Yamanaka K; Wakisaka Y; Kitazono T
    eNeuro; 2020; 7(2):. PubMed ID: 32046974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice.
    Zhang Y; Nakano D; Guan Y; Hitomi H; Uemura A; Masaki T; Kobara H; Sugaya T; Nishiyama A
    Kidney Int; 2018 Sep; 94(3):524-535. PubMed ID: 30045814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canagliflozin, an Inhibitor of the Na
    Shim B; Stokum JA; Moyer M; Tsymbalyuk N; Tsymbalyuk O; Keledjian K; Ivanova S; Tosun C; Gerzanich V; Simard JM
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of sodium glucose co-transporter 2 in mesangial cells and pericytes and its roles in mesangial lesions and in capillaries under diabetic and ischemic conditions.
    Wakisaka M; Nakamura K; Kitazono T
    Diabetes Res Clin Pract; 2022 Oct; 192():110096. PubMed ID: 36174778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luseogliflozin inhibits high glucose-induced TGF-
    Osaka N; Mori Y; Terasaki M; Hiromura M; Saito T; Yashima H; Shiraga Y; Kawakami R; Ohara M; Fukui T; Yamagishi SI
    J Int Med Res; 2022 May; 50(5):3000605221097490. PubMed ID: 35510669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detrimental role of pericyte Nox4 in the acute phase of brain ischemia.
    Nishimura A; Ago T; Kuroda J; Arimura K; Tachibana M; Nakamura K; Wakisaka Y; Sadoshima J; Iihara K; Kitazono T
    J Cereb Blood Flow Metab; 2016 Jun; 36(6):1143-54. PubMed ID: 26661159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild traumatic brain injury induces pericyte detachment independent of stroke vulnerability.
    Whitehead B; Corbin D; Albowaidey A; Zhang N; Karelina K; Weil ZM
    Neurosci Lett; 2024 Jan; 818():137552. PubMed ID: 37949292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iptakalim improves cerebral microcirculation in mice after ischemic stroke by inhibiting pericyte contraction.
    Guo RB; Dong YF; Yin Z; Cai ZY; Yang J; Ji J; Sun YQ; Huang XX; Xue TF; Cheng H; Zhou XQ; Sun XL
    Acta Pharmacol Sin; 2022 Jun; 43(6):1349-1359. PubMed ID: 34697419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level.
    Katsuno K; Fujimori Y; Takemura Y; Hiratochi M; Itoh F; Komatsu Y; Fujikura H; Isaji M
    J Pharmacol Exp Ther; 2007 Jan; 320(1):323-30. PubMed ID: 17050778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luseogliflozin for the treatment of type 2 diabetes.
    Seino Y
    Expert Opin Pharmacother; 2014 Dec; 15(18):2741-9. PubMed ID: 25359155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell profiling of brain pericyte heterogeneity following ischemic stroke unveils distinct pericyte subtype-targeted neural reprogramming potential and its underlying mechanisms.
    Loan A; Awaja N; Lui M; Syal C; Sun Y; Sarma SN; Chona R; Johnston WB; Cordova A; Saraf D; Nakhlé A; O'Connor K; Thomas J; Leung J; Seegobin M; He L; Wondisford FE; Picketts DJ; Tsai EC; Chan HM; Wang J
    Theranostics; 2024; 14(16):6110-6137. PubMed ID: 39431007
    [No Abstract]   [Full Text] [Related]  

  • 14. Notoginsenoside R1 ameliorates mitochondrial dysfunction to circumvent neuronal energy failure in acute phase of focal cerebral ischemia.
    Liu B; Zhao T; Li Y; Han Y; Xu Y; Yang H; Wang S; Zhao Y; Li P; Wang Y
    Phytother Res; 2022 May; 36(5):2223-2235. PubMed ID: 35419891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro characterization of luseogliflozin, a potent and competitive sodium glucose co-transporter 2 inhibitor: Inhibition kinetics and binding studies.
    Uchida S; Mitani A; Gunji E; Takahashi T; Yamamoto K
    J Pharmacol Sci; 2015 May; 128(1):54-7. PubMed ID: 26003086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of platelet-derived growth factor receptor β in fibrosis through extracellular matrix protein production after ischemic stroke.
    Makihara N; Arimura K; Ago T; Tachibana M; Nishimura A; Nakamura K; Matsuo R; Wakisaka Y; Kuroda J; Sugimori H; Kamouchi M; Kitazono T
    Exp Neurol; 2015 Feb; 264():127-34. PubMed ID: 25510317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Therapeutic Effects of Sodium Glucose-linked Cotransporter 2 Inhibitors in Stroke.
    Al Hamed FA; Elewa H
    Clin Ther; 2020 Nov; 42(11):e242-e249. PubMed ID: 33008610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: A possible role of SGLT2 in mesangial cells.
    Maki T; Maeno S; Maeda Y; Yamato M; Sonoda N; Ogawa Y; Wakisaka M; Inoguchi T
    Sci Rep; 2019 Mar; 9(1):4703. PubMed ID: 30886225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pericyte hypoxia-inducible factor-1 (HIF-1) drives blood-brain barrier disruption and impacts acute ischemic stroke outcome.
    Tsao CC; Baumann J; Huang SF; Kindler D; Schroeter A; Kachappilly N; Gassmann M; Rudin M; Ogunshola OO
    Angiogenesis; 2021 Nov; 24(4):823-842. PubMed ID: 34046769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of basic FGF in the upregulation of PDGFRβ in pericytes after ischemic stroke.
    Nakamura K; Arimura K; Nishimura A; Tachibana M; Yoshikawa Y; Makihara N; Wakisaka Y; Kuroda J; Kamouchi M; Ooboshi H; Kitazono T; Ago T
    Brain Res; 2016 Jan; 1630():98-108. PubMed ID: 26569132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.